UK: Reports of Miscarriages After Vaccination

Home / Covid-19 Vaccines, PCR Tests & Masks / UK: Reports of Miscarriages After Vaccination
UK: Reports of Miscarriages After Vaccination
In the UK, pregnant women had previously been urged not to be vaccinated against Covid-19, as risks to unborn children could not be ruled out.

by Free West Media
April 20, 2021


When authorities presented the first summary of reported side effects on 24 January, there were six miscarriages (four from Pfizer’s vaccine, two from AstraZeneca).

“We still do not know why these women received the Covid vaccine, contrary to the government’s own advice. But what is really shocking is how much this number has increased in the six weeks that have passed since then,” reported the online newspaper Daily Expose. It presented updated figures from the turn of the month March/April.

These showed that there were now a total of 23 women who had had a miscarriage after being vaccinated with Pfizer-BioNTech. Of those who have received AstraZeneca’s vaccine, the total number is five.

The total of 28 miscarriages is an increase of 366 percent from the January figure.

The fact that pregnant women in some cases are being given the vaccine is due to the government updating its recommendation recently because the benefits allegedly outweigh the risks to the mother and the child.

The original recommendation stated:

“There is no or a limited amount of data from the use of COVID-19 mRNA vaccine BNT162b2. Reproductive toxicity studies in animals have not been completed. COVID-19 mRNA vaccine BNT162b2 is not recommended during pregnancy. For women of childbearing potential, pregnancy should be ruled out before vaccination. In addition, women of childbearing potential should be advised to avoid pregnancy for at least 2 months after the second dose.”

The updated recommendation now reads:

“There is limited experience with the use of COVID-19 mRNA vaccine BNT162b2 in pregnant women. Animal studies do not indicate direct or indirect harmful effects with respect to pregnancy, embryonal / fetal development, parturition or postnatal development. Administration of COVID-19 mRNA vaccine BNT162b2 during pregnancy should be considered only when the potential benefits outweigh the potential risks to the mother and the fetus.”


Connect with Free West Media

Print Friendly, PDF & Email